The Centers for Medicare & Medicaid Services’ proposed rule on the standards governing health insurance issuers and the Health Insurance Marketplaces for 2021 includes a number of policies that could benefit patients by lowering drug prices and premiums, incentivizing use of high-value services and ensuring premium dollars are spent wisely, AHA said in comments submitted yesterday.

“We are concerned, however, that CMS continues to consider changes to automatic reenrollment, which could result in the loss of coverage for vulnerable enrollees and contribute to marketplace destabilization,” AHA said. “We are also concerned about the continued rise in annual cost-sharing limits, which many Americans already struggle to afford.”

AHA encouraged the agency to “go further in future rulemaking to advance policies that will not only maintain the status quo but also build on the progress already made. Such policies include substantially increasing funding for outreach and enrollment efforts, extending the open enrollment period, and increasing lower- and middle-income individuals and families’ access to premium tax credits.”
 

Headline
A survey released June 4 by the Commonwealth Fund on insurance coverage denials found that 1 in 5 privately insured U.S. adults reported that they or a family…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The Centers for Medicare & Medicaid Services June 1 issued an interim final rule with comment period implementing the statutory requirement that certain…
Headline
The House Education and Workforce Committee May 21 unanimously passed the Transparency in Billing Act (H.R. 8684). The bill would require off-campus hospital…
Headline
The Centers for Medicare & Medicaid Services May 20 released a proposed rule that would modify policies governing Medicaid state-directed…
Headline
The White House May 18 announced an expansion of TrumpRx.gov, which now features more than 600 generic drugs. The direct-to-consumer platform serves as a hub…